Catalog No.
RHA19301
Species reactivity
Human
Host species
Rabbit
Isotype
IgG
Clonality
Monoclonal
Tested applications
IF: 1:50-1:200, IHC: 1:50-1:100, IP: 1:20, WB: 1:500-1:1000
Target
Stearoyl-CoA desaturase, Fatty acid desaturase, Acyl-CoA desaturase, SCD, Delta(9)-desaturase, hSCD1, SCDOS, SCD1, FADS5, Delta-9 desaturase
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
O00767
Applications
IF, IHC, IP, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.
Clone ID
R1D09
Coexisting systemic lupus erythematosus with lupus nephritis and sickle cell trait: a case report of rare combination., PMID:40486540
Treatment of breast cancer in a patient with sickle cell disease., PMID:40484435
Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency., PMID:40445758
Determining the FY*BES Allele in Iranian Sickle Cell Disease Patients to Enhance Matching Blood Transfusion., PMID:40421394
Preclinical therapeutics for sickle cell disease: modern developments and future considerations., PMID:40323290
Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE binding., PMID:40311815
Haemato-Urological Profile and Asymptomatic Urinary Tract Infection in Ghanaian Steady-State Sickle Cell Disease Patients: A Case-Control Study., PMID:40256135
Cardiovascular Disorders in Systemic Lupus Erythematosus., PMID:40207823
A Prognostic Index for Deceased Donor Kidneys and Criteria for Identifying Suitable Candidates for Kidney Transplantation from Expanded Criteria Donors with Prolonged Waiting Times., PMID:40160491
Fibroblast growth factor 23 neutralizing antibody partially rescues bone loss and increases hematocrit in sickle cell disease mice., PMID:40155665
Impact of Different Definitions of Vaso-Occlusion on Efficacy Assessments in Sickle Cell Disease Clinical Trials., PMID:40146367
Evaluation of Cellular Immune Responses After mRNA-1273 Vaccination in Children 6 Months to 11 Years of Age., PMID:40119775
Subjective cognitive decline in conjunction with cerebrospinal fluid anti-ATP1A3 autoantibodies and a low amyloid β 1-42/1-40 ratio: Report and literature review., PMID:40101839
The prevalence and pattern of alloimmunization in patients with sickle cell disease in Abuja, Nigeria., PMID:40086348
Accelerated drug approvals and patient trust: impact of voxelotor and crizanlizumab for sickle cell disease., PMID:40085957
A Meta Analysis of RBC Alloimmunization in Transfused Sickle Cell and Thalassemia Patients in Saudi Arabia., PMID:40066558
Two Nonmyeloablative HLA-Matched Related Donor Allogeneic Hematopoietic Cell Transplantation Regimens in Patients with Severe Sickle Cell Disease., PMID:40010689
Structure Bioinformatics of Six Human Integral Transmembrane Enzymes and their AlphaFold3 Predicted Water-Soluble QTY Analogs: Insights into FACE1 and STEA4 Binding Mechanisms., PMID:39966220
Associations of Cerebrospinal Fluid Orexin-A, Alzheimer Disease Biomarkers, and Cognitive Performance., PMID:39957622
Systemic Inflammatory Diseases in Children With Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues., PMID:39871404
Profiles of systemic lupus erythematosus patients with co-existing sickle cell disease: a coincidence or true association?, PMID:39866301
Frequency of autoantibodies and their associated clinical characteristics and outcomes in patients with dilated cardiomyopathy: A systematic review and meta-analysis., PMID:39855285
A review on disease modifying pharmacologic therapies for sickle cell disease., PMID:39828781
Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review., PMID:39783839
Systemic lupus erythematosus-associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice., PMID:39748216
Invasive cervical root resorption in a cancer patient: A rare case report with 2 years of follow-up and literature review., PMID:39707926
Co-existence of autoimmune polyglandular syndrome type 3b and undifferentiated connective tissue disease with subacute combined degeneration of spinal cord in children: a case report and literature review., PMID:39695483
IFN-I promotes T-cell-independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD., PMID:39656114
Practical guide for disease-modifying medication management of children and adolescents with sickle cell disease., PMID:39644011
Prevalence and Possible Predictors of Helicobacter Pylori Infection Among Adult Patients with Sickle Cell Disease in Ahmadu Bello University Teaching Hospital North-West, Nigeria., PMID:39633701
Vector-Free Deep Tissue Targeting of DNA/RNA Therapeutics via Single Capacitive Discharge Conductivity-Clamped Gene Electrotransfer., PMID:39601152
Red cell specifications for blood group matching in patients with haemoglobinopathies: An updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines., PMID:39535318
Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease: final results from the phase II SOLACE-adults study., PMID:39497751
Real-World Evidence of Crizanlizumab Showing Reductions in Vaso-Occlusive Crises and Opioid Usage in Sickle Cell Disease., PMID:39473076
Management of immune-mediated glomerular diseases in the elderly., PMID:39378123
A Case Report of Red Blood Cell Alloimmunization and Delayed Hemolytic Transfusion Reaction in a Patient with an Uncommon Phenotype in Sickle Cell Disease: Review of Diagnosis and Management., PMID:39345990
Immune Cell Profiles of Patients with Sickle Cell Disease during Parvovirus B19-Induced Transient Red Cell Aplasia., PMID:39340016
Investigation of Delayed Transfusion Reactions in Sickle Cell Disease Patients Polytransfused in the Brazilian Amazon., PMID:39189245
Cathepsin C in health and disease: from structural insights to therapeutic prospects., PMID:39164687
Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease., PMID:39134876
Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako., PMID:39104031
Seroprevalence of SARS-CoV-2 in pediatric hematology-oncology patients., PMID:39039770
Chronic automated red cell exchange therapy for sickle cell disease., PMID:39003570
COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study., PMID:38991137
Current and emerging drug treatment strategies to tackle sickle cell anemia., PMID:38988318
A genome-wide association study of alloimmunization in the TOPMed OMG-SCD cohort identifies a locus on chromosome 12., PMID:38966903
Mandibular fracture in medication-associated osteonecrosis following infliximab therapy: A case report., PMID:38961587
Red Cell Alloimmunisation Among Sickle Cell Disease and Thalassemia Patients Following Rh- and K-Matched Red Cell Transfusion in Southwestern Saudi Arabia: A Multicenter Study., PMID:38947563
Immune modulation permits tolerance and engraftment in a murine model of late-gestation transplantation., PMID:38941538
Complex Transfusion Management in a Sickle Cell Patient With Anti-Fy3 Alloimmunization: A Case Report., PMID:38910632
For research use only. Not for human or drug use.
